Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
出版年份 2013 全文链接
标题
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
作者
关键词
-
出版物
Nature Communications
Volume 4, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-10-01
DOI
10.1038/ncomms3516
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
- (2013) Triantafyllos Stylianopoulos et al. CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Angiotensin II Type 1A Receptor Signaling Facilitates Tumor Metastasis Formation through P-Selectin–Mediated Interaction of Tumor Cells with Platelets and Endothelial Cells
- (2012) Hideki Amano et al. AMERICAN JOURNAL OF PATHOLOGY
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms
- (2012) Mariya T. Sweetwyne et al. MATRIX BIOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
- (2012) Shanna A. Arnold et al. PLoS One
- Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
- (2012) Sylvie Rodrigues-Ferreira et al. PLoS One
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
- (2012) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluorescent Nanorods and Nanospheres for Real-Time In Vivo Probing of Nanoparticle Shape-Dependent Tumor Penetration
- (2011) Vikash P. Chauhan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired lymphatic contraction associated with immunosuppression
- (2011) S. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scaling rules for diffusive drug delivery in tumor and normal tissues
- (2011) James W. Baish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
- (2011) J. P. Habashi et al. SCIENCE
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
- (2010) Chiyo Doi et al. BMC CANCER
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
- (2010) K. L. Cook et al. CANCER RESEARCH
- Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
- (2010) Walid S Kamoun et al. NATURE METHODS
- Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways
- (2009) Fuye Yang et al. HYPERTENSION
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
- (2009) Benjamin J Vakoc et al. NATURE MEDICINE
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis
- (2008) Barbara Ulmasov et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
- (2008) Andrew Leask CELLULAR SIGNALLING
- Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy
- (2008) Mi-Suk Park et al. RADIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started